Allergy Immunotherapy with Depigmented Glutaraldehyde-Polymerized Extracts

Allergy Immunotherapy
Allergic rhinitis is a very common problem associated with poor quality of life, reductions in social and work activities and poor interpersonal relationships. The main goal of the management of allergic rhinitis is to improve the quality of life. Immunotherapy is a specific therapy for allergic rhinitis and several reports have documented the safety and efficacy of this treatment . Safety has been a key issue in immunotherapy and various modalities are being investigated to make allergy immunotherapy more tolerable and safe to administer. (more…)

Immunotherapy Safety: Standardized Therapeutic Vaccines For Allergic Diseases

Immunotherapy Safety
The safety of immunotherapy has been a constraint on this form of treatment for allergic disease. Although retrospective survey studies of fatal reactions have been undertaken in North American practices, few European studies have been reported concerning fatal and non-fatal reactions to immunotherapy.

Allergy immunotherapy is stimulation of your immune system along with progressively growing dosages of the elements to that a person is allergic. (more…)

Allergic Rhinitis Asthma Symptoms and Syndrome

Allergic Rhinitis Asthma
Allergic rhinitis is a high-prevalence disease. This high prevalence translates into a high cost to society in terms of overall healthcare utilization, and also a high cost in terms of the quality of life of those who suffer from moderate or severe disease.

Allergic rhinitis has traditionally been divided into seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR). This classification is helpful in indicating the season of maximum symptoms and the likely causative allergens immunotherapy. (more…)

Beware of Fatal Immunotherapy Reactions To Allergen Injections And Skin Testing

Allergen Injections
Allergen immunotherapy has proven to be effective in the management of allergic disease and is the only treatment that is able to modify the natural course of the disease. Its wider applicability for the treatment of allergic disease has, in part, been limited by its perceived safety profile. This study follows up previous fatal reaction surveys undertaken in the USA for the periods 1959–1984 and 1985–1989. (more…)